FSRKX
Price
$9.53
Change
+$0.01 (+0.11%)
Updated
Jul 24 closing price
Net Assets
517.11M
HBLCX
Price
$14.59
Change
+$0.05 (+0.34%)
Updated
Jul 24 closing price
Net Assets
11.01B
Interact to see
Advertisement

FSRKX vs HBLCX

FSRKX vs HBLCX Comparison Chart in %
View a ticker or compare two or three
VS
FSRKX vs. HBLCX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSRKX is a Hold and HBLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLCX has more cash in the bank: 11B vs. FSRKX (517M). FSRKX pays higher dividends than HBLCX: FSRKX (4.36) vs HBLCX (2.47). FSRKX was incepted earlier than HBLCX: FSRKX (7 years) vs HBLCX (20 years). HBLCX (1.65) is less costly to investors than FSRKX (0.64). HBLCX is a more actively managed with annual turnover of: 90.00 vs. FSRKX (29.00). FSRKX has a lower initial minimum investment than HBLCX: FSRKX (0) vs HBLCX (2000). FSRKX annual gain was more profitable for investors over the last year : 14.10 vs. HBLCX (2.70). FSRKX return over 5 years is better than : 35.22 vs. HBLCX (1.05).
FSRKXHBLCXFSRKX / HBLCX
Total Expense Ratio0.511.6531%
Annual Report Gross Expense Ratio0.641.6539%
Fund Existence7 years20 years-
Gain YTD8.9503.311270%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/A2000-
Net Assets517M11B5%
Annual Yield % from dividends4.362.47177%
Returns for 1 year14.102.70522%
Returns for 3 years29.3513.89211%
Returns for 5 years35.221.053,343%
Returns for 10 yearsN/A27.84-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCMT27.630.08
+0.29%
RCM Technologies
LHX300.210.54
+0.18%
L3Harris Technologies
KNSA62.84-0.21
-0.33%
Kiniksa Pharmaceuticals International plc
OLMA11.70-0.04
-0.34%
Olema Pharmaceuticals
ALAR1.88-0.06
-3.09%
Alarum Technologies Ltd